Evidence map›Paper›PMID 40838067›Full record

ArticleFrontiers in drug delivery2023

Development of a depot formulation with an

Hiroaki Todo, Rina Niki, Akie Okada, Ibuki Narita, Kazuya Inamura, Ayu Ito, Shoko Itakura, Ichiro Hijikuro, Kenji Sugibayashi

Abstract read
In one paragraph

Article in Frontiers in drug delivery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroaki TodoFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
Rina NikiFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
Akie OkadaFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
Ibuki NaritaFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
Kazuya InamuraFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
Ayu ItoFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
Shoko ItakuraFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
Ichiro HijikuroFarnex Incorporated, Yokohama Joint Research Center, Yokohama, Japan.
Kenji SugibayashiFaculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-lamellar liquid crystal (NLLC) structures have gained increasing attention for the controlled release of entrapped drugs. In the present study, an

Indexed as

in situ forming systemlipid-based depot formulationlong-acting drug delivery systemnon-lamellar liquid crystalsustained release

Identifiers

PMID40838067
PMCPMC12363284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.